$FIGS

What FIGS (FIGS)'s Earnings Beat And Margin Gains Mean For Shareholders

FIGS reported Q2 2026 earnings with EPS of $0.15, beating expectations, and improved margins. Revenue reached $196.62M, up from the prior year. Management increased share repurchase authorization by $100M to $200M. Analysts project 2029 revenue of $918.9M and earnings of $72.9M, a 21% upside to current price.

Original reporting
Published Aug 31, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What FIGS (FIGS)'s Earnings Beat And Margin Gains Mean For Shareholders — source image
Decision brief

The 30-second read

$FIGSBullishMed
01

Why it matters

Earnings beat and margin improvement provide fresh catalyst for price appreciation, but risks remain around tariffs and promotion costs.

02

Market read

Earnings surprise offers a short‑term trading opportunity in a small‑cap growth stock.

03

What to watch

Increased share repurchase could limit cash for growth initiatives.

Relevance 7/10Novelty 7/10Timing: post‑earnings release

Background

FIGS is a direct‑to‑consumer healthcare apparel company listed on NYSE, recently expanding its share buyback program.

Company-level read

Ticker impact

$FIGSBullishHigh confidence
Context

Q2 2026 earnings beat with EPS $0.15 and margin improvement, sales $196.62M, prompting share repurchase increase.

Expected impact

Potential 5-10% upside over the next week if momentum holds.

Evidence & confidence

Earnings beat and margin expansion are fresh, material data for a growth‑stage company; investors often reward such surprises.

Market effects

Highlights strength in direct‑to‑consumer healthcare apparel, may lift peer valuations.

U.S. small‑cap growth segment sees renewed interest.

Limited to U.S. market; no immediate global macro effect.

Counterpoint

Margin gains may be temporary if tariff and sourcing pressures intensify.

Key entities

  • FIGS

    NYSE‑listed healthcare apparel retailer.

Related articles

$FIGSHighAI 9/10

FIGS (FIGS) Q2 2026 Earnings Call Transcript

FIGS, Inc. (FIGS) reported Q2 2026 net revenues of $196.6 million, up 28.8%, driven by higher order volume and record average order values. Scrubwear revenue rose 26.5% to $161.2 million. Gross margin was 75.2% and net income $28.4 million. The company raised FY2026 net revenue guidance to about 20% growth and EBITDA margin to 14.8% to 15.0%.

$FIGSMedAI 8/10

FIGS Stock Soars After Earnings Beat And Upgraded Outlook

FIGS Inc. (NYSE: FIGS) shares rose about 28.7% in a week after a Q2 earnings beat and an upgraded FY26 outlook, according to the article. Q2 results included EPS $0.15 vs $0.07 and revenue up 29% to $196.6M, with gross margin 66.6% and adjusted EBITDA margin 18.6%. FY26 guidance was raised to about 20% revenue growth and 14.8% to 15% EBITDA margin.

$FIGSHighAI 9/10

FIGS Q2 Earnings Call Highlights

FIGS (NYSE:FIGS) reported Q2 results and an earnings call update. International revenue rose 67% to $37.9M and U.S. revenue grew 22% to $158.7M. Gross margin increased to 75.2% with a $15.4M tariff refund benefit. Net income was $28.4M, or $0.15/share. FIGS raised FY2026 revenue growth to ~20% and operating margin to ~10.8%, and repurchased about $24M of shares.

$FIGSHighAI 9/10

FIGS Stock Jumped 27% on Its Q2 Beat. The Raised Guide Did the Real Work.

FIGS (FIGS) shares rose about 27% on Aug. 7 after Q2 results beat estimates and management raised full-year guidance. Q2 revenue was $196.6M (+29% YoY) and EPS was $0.15 vs $0.07 consensus. Gross margin hit 75.2% but included a one-time tariff refund; core margin improved. Full-year growth guidance lifted to ~20% from 14% to 16%, plus a $100M buyback authorization.

$FIGSMedAI 8/10

FIGS, Inc. Lifts Outlook Amid Robust Growth

FIGS, Inc. (FIGS) reported Q2 results and lifted full-year revenue growth guidance to about 20%. Net revenues rose 29% to $196.6M, with gross margin up 820 bps to 75.2% and operating margin to 17.9%. Management cited $20.5M tariff refunds and raised 2026 operating margin and adjusted EBITDA outlooks, while noting Q3 margin pressure from a Jordan import hold and airfreight.